Literature DB >> 23460689

Effect of rotavirus vaccine on diarrhea mortality in different socioeconomic regions of Mexico.

Paul A Gastañaduy1, Edgar Sánchez-Uribe, Marcelino Esparza-Aguilar, Rishi Desai, Umesh D Parashar, Manish Patel, Vesta Richardson.   

Abstract

OBJECTIVE: In Mexico, declines in childhood diarrhea deaths have been documented during 2008-2010 after rotavirus vaccine introduction in 2007. Because of concerns about variation in rotavirus vaccine efficacy by socioeconomic status, we compared reductions in diarrhea mortality in the lesser developed southern region versus the more developed northern and central regions of Mexico.
METHODS: We obtained data from national vital statistics on diarrhea deaths among children aged <5 years from 2002 through 2011. We compared region-specific diarrhea mortality before (2003-2006) and after (2009-2011) vaccine introduction. Regional vaccine coverage was estimated from administrative data, and socioeconomic status was assessed by using the Human Development Index.
RESULTS: In northern, central, and southern Mexico, the 2007 Human Development Index was 0.84, 0.82, and 0.77, respectively, and by 2010 an estimated 99%, 84%, and 89% of children aged <12 months had completed rotavirus vaccination. Diarrhea mortality among children <5 years old declined from 8.3, 17.9, and 28.5 deaths per 100,000 children during 2003-2006 to 4.5, 8.1, and 16.2 in 2009-2011 in northern, central, and southern Mexico, respectively, corresponding to rate reductions of 45%, 55%, and 43%. No significant differences were observed in rate reductions between regions (P > .8).
CONCLUSIONS: After introduction of rotavirus vaccination, marked and sustained declines in diarrhea deaths were seen among children in all regions of Mexico, including in the least developed southern region with the highest baseline diarrhea mortality. This finding indicates equitable vaccine delivery to children with varying risk of mortality and reaffirms the beneficial effects of rotavirus vaccination against fatal diarrheal disease.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23460689     DOI: 10.1542/peds.2012-2797

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  11 in total

1.  Impact of Rotavirus Vaccination on Hospitalizations and Deaths From Childhood Gastroenteritis in Botswana.

Authors:  Leslie A Enane; Paul A Gastañaduy; David M Goldfarb; Jeffrey M Pernica; Margaret Mokomane; Banno Moorad; Lingani Masole; Jacqueline E Tate; Umesh D Parashar; Andrew P Steenhoff
Journal:  Clin Infect Dis       Date:  2016-05-01       Impact factor: 9.079

2.  Molecular epidemiology of contemporary G2P[4] human rotaviruses cocirculating in a single U.S. community: footprints of a globally transitioning genotype.

Authors:  Allison F Dennis; Sarah M McDonald; Daniel C Payne; Slavica Mijatovic-Rustempasic; Mathew D Esona; Kathryn M Edwards; James D Chappell; John T Patton
Journal:  J Virol       Date:  2014-01-15       Impact factor: 5.103

3.  Potential safety issues and other factors that may affect the introduction and uptake of rotavirus vaccines.

Authors:  N Aliabadi; J E Tate; U D Parashar
Journal:  Clin Microbiol Infect       Date:  2016-04-26       Impact factor: 8.067

4.  Hospitalizations and Deaths Because of Respiratory and Diarrheal Diseases Among Haitian Children Under Five Years of Age, 2011-2013.

Authors:  Kavita Vinekar; Nicolas Schaad; Mentor Ali Ber Lucien; Eyal Leshem; Ikwo K Oboho; Gerard Joseph; Stanley Juin; Fatimah S Dawood; Umesh Parashar; Mark A Katz; Rania A Tohme
Journal:  Pediatr Infect Dis J       Date:  2015-10       Impact factor: 2.129

5.  Methods and challenges for the health impact assessment of vaccination programs in Latin America.

Authors:  Ana Marli Christovam Sartori; Andréia de Fátima Nascimento; Tânia Yuka Yuba; Patrícia Coelho de Soárez; Hillegonda Maria Dutilh Novaes
Journal:  Rev Saude Publica       Date:  2016-01-15       Impact factor: 2.106

6.  Rates of hospitalization and death for all-cause and rotavirus acute gastroenteritis before rotavirus vaccine introduction in Kenya, 2010-2013.

Authors:  Richard Omore; Sammy Khagayi; Billy Ogwel; Reuben Onkoba; John B Ochieng; Jane Juma; Stephen Munga; Collins Tabu; Sergon Kibet; J Pekka Nuorti; Frank Odhiambo; Jason M Mwenda; Robert F Breiman; Umesh D Parashar; Jacqueline E Tate
Journal:  BMC Infect Dis       Date:  2019-01-11       Impact factor: 3.090

Review 7.  Sustaining Vaccine Confidence in the 21st Century.

Authors:  Karin Hardt; Ruprecht Schmidt-Ott; Steffen Glismann; Richard A Adegbola; François P Meurice
Journal:  Vaccines (Basel)       Date:  2013-06-24

8.  Further characterisation of rotavirus cores: Ss(+)RNAs can be packaged in vitro but packaging lacks sequence specificity.

Authors:  Ulrich Desselberger; James Richards; Luba Tchertanov; Jean Lepault; Andrew Lever; Oscar Burrone; Jean Cohen
Journal:  Virus Res       Date:  2013-10-01       Impact factor: 3.303

Review 9.  Effectiveness of rotavirus vaccines against rotavirus infection and hospitalization in Latin America: systematic review and meta-analysis.

Authors:  Victor S Santos; Daniella P Marques; Paulo R S Martins-Filho; Luis E Cuevas; Ricardo Q Gurgel
Journal:  Infect Dis Poverty       Date:  2016-08-12       Impact factor: 4.520

10.  Hospitalizations and Deaths Associated with Diarrhea and Respiratory Diseases among Children Aged 0⁻5 Years in a Referral Hospital of Mauritania.

Authors:  Mohamed Lemine Cheikh Brahim Ahmed; Abdellahi Weddih; Mohammed Benhafid; Mohamed Abdellahi Bollahi; Mariem Sidatt; Khattry Makhalla; Ali H Mokdad; Jorg Heukelbach; Abdelkarim Filali-Maltouf
Journal:  Trop Med Infect Dis       Date:  2018-09-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.